日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Timelines to initiate a phase III trial across the globe: a sub-analysis of the APHINITY trial

全球范围内启动 III 期临床试验的时间表:APHINITY 试验的子分析

Franzoi, Maria Alice; Procter, Marion; Twelves, Chris; Ponde, Noam; Eiger, Daniel; Emond, Orianne; Clark, Emma; Parlier, Damien; Guillaume, Sébastien; Reaby, Linda; de Azambuja, Evandro; Bines, Jose

Patient-reported function, health-related quality of life, and symptoms in APHINITY: pertuzumab plus trastuzumab and chemotherapy in HER2-positive early breast cancer

APHINITY研究中患者报告的功能、健康相关生活质量和症状:帕妥珠单抗联合曲妥珠单抗和化疗治疗HER2阳性早期乳腺癌

Bines, José; Clark, Emma; Barton, Claire; Restuccia, Eleonora; Procter, Marion; Sonnenblick, Amir; Fumagalli, Debora; Parlier, Damien; Arahmani, Amal; Baselga, José; Viale, Giuseppe; Reaby, Linda L; Frank, Elizabeth; Gelber, Richard D; Piccart, Martine; Jackisch, Christian; Petersen, Jennifer A

Improving informed consent: pilot of a decision aid for women invited to participate in a breast cancer prevention trial (IBIS-II DCIS)

改进知情同意:一项针对受邀参与乳腺癌预防试验(IBIS-II DCIS)的女性的决策辅助工具试点项目

Juraskova, I; Butow, P; Lopez, A; Seccombe, M; Coates, A; Boyle, F; McCarthy, N; Reaby, L; Forbes, J F